Study on the mechanism of Shenmai injection in the treatment of sepsis DOI Creative Commons
Mengxia Yang, Tengfei Chen, Yue Xu

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(22)

Опубликована: Ноя. 1, 2024

Abstract Shenmai injection (SMI) is widely used in the clinical treatment of sepsis, but its mechanism not yet clear. This study aimed to explore molecular through network pharmacology, bioinformatics, and docking technologies. The active ingredients targets SMI were screened traditional Chinese medicine databases Swiss Target Prediction database, respectively. disease genes searched using GEO GeneCards databases, Venn mapping was screen potential therapeutic targets. key selected Cytoscape 3.9.1 software. BioGPS database evaluate expression these tissues/cells. DAVID for enrichment analysis. Molecular technology interaction between core ingredients. 122 28 identified. Forty‐six showed highly specific 40 PI3K‐AKT, RAP1, MAPK signalling pathways are enriched. results good interactions. systematically analysed treating involving multiple pathways, possibly related anti‐inflammatory, anti‐oxidative stress, immune regulation, providing reference value future basic research sepsis.

Язык: Английский

Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery DOI Creative Commons
Junyu Wu, Guping Tang, Chien‐shan Cheng

и другие.

Molecular Cancer, Год журнала: 2024, Номер 23(1)

Опубликована: Окт. 1, 2024

Язык: Английский

Процитировано

14

Host-microbiota interactions in collagen-induced arthritis rats treated with human umbilical cord mesenchymal stem cell exosome and ginsenoside Rh2 DOI Open Access

Zhongsheng Zhou,

Yang Li,

Shuhui Wu

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 174, С. 116515 - 116515

Опубликована: Апрель 2, 2024

Mesenchymal stem cell exosome (MSCs-exo) is a class of products secreted by mesenchymal cells (MSCs) that contain various biologically active substances. MSCs-exo promising alternative to MSCs due their lower immunogenicity and lack ethical constraints. Ginsenoside Rh2 (Rh2) hydrolyzed component the primary substance ginsenosides. has variety pharmacological functions, including anti-inflammatory, anti-tumor, antioxidant. Studies have demonstrated gut microbiota metabolites are critical in developing rheumatoid arthritis (RA). In this study, we constructed collagen-induced (CIA) model rats. We used combined with treat CIA To observe effect on joint inflammation, rat feces were collected for 16 rRNA amplicon sequencing untargeted metabolomics analysis. The results showed index score swelling rats treated combination significantly than those alone groups. ameliorated disturbed regulation Candidatus_Saccharibacteria Clostridium_XlVb may be most critical. enhanced therapeutic compared -alone group. Furthermore, significant changes observed group, these differentially altered act as messengers host-microbiota interactions. These differential enriched into relevant metabolic pathways, revealing possible pathways

Язык: Английский

Процитировано

5

Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer DOI Creative Commons
Xiyu Liu, Jingjing Li, Qingqing Huang

и другие.

Molecular Medicine, Год журнала: 2024, Номер 30(1)

Опубликована: Апрель 26, 2024

Ginsenoside Rh2 (G-Rh2), a steroidal compound extracted from roots of ginseng, has been extensively studied in tumor therapy. However, its specific regulatory mechanism non-small cell lung cancer (NSCLC) is not well understood. Pyruvate dehydrogenase kinase 4 (PDK4), central regulator cellular energy metabolism, highly expressed various malignant tumors. We investigated the impact G-Rh2 on progression NSCLC and how it regulated PDK4 to influence aerobic glycolysis mitochondrial function.

Язык: Английский

Процитировано

5

Ginsenoside-Rh2 Promotes Functional Recovery after Spinal Cord Injury by Enhancing TFEB-Mediated Autophagy DOI

Rongjie Liu,

Liting Jiang,

Yituo Chen

и другие.

Journal of Agricultural and Food Chemistry, Год журнала: 2024, Номер 72(26), С. 14727 - 14746

Опубликована: Июнь 22, 2024

: Following spinal cord injury (SCI), autophagy plays a positive role in neuronal protection, whereas pyroptosis triggers an inflammatory response. Ginsenoside-Rh2 (GRh2), known for its neuroprotective effects, is considered promising drug. However, the exact molecular mechanisms underlying these protective effects remain unclear.

Язык: Английский

Процитировано

4

Ginsenosides: an immunomodulator for the treatment of colorectal cancer DOI Creative Commons

Jianan Qian,

Yanyu Jiang, Hongyi Hu

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Июнь 12, 2024

Ginsenosides, the primary bioactive ingredients derived from root of Panax ginseng, are eagerly in demand for tumor patients as a complementary and alternative drug. Ginsenosides have increasingly become “hot topic” recent years due to their multifunctional role treating colorectal cancer (CRC) regulating microenvironment (TME). Emerging experimental research on ginsenosides treatment immune regulation CRC has been published, while no review sums up its specific microenvironment. Therefore, this paper systematically introduces how affect TME, specifically by enhancing response, inhibiting activation stromal cells, altering hallmarks cells. In addition, we discuss impact physicochemical properties Furthermore, application clinical efficacy patient immunity prolonging survival. The future perspectives ginsenoside drug also provided. This hopes open new horizon Traditional Chinese Medicine monomers.

Язык: Английский

Процитировано

3

PARP14 inhibits microglial activation via NNT to alleviate depressive-like behaviors in mice DOI
Xiaoyu Yu, Tingting Yang, Di Wu

и другие.

Brain Behavior and Immunity, Год журнала: 2025, Номер 126, С. 235 - 246

Опубликована: Фев. 18, 2025

Язык: Английский

Процитировано

0

Ginsenoside Rh2 Ameliorates Myocardial Infarction by Regulating Cardiomyocyte Pyroptosis Based on Network Pharmacology, Molecular Docking, and Experimental Verification DOI
Bing Li, Shuanglong Mou, Chenrui Zhang

и другие.

The American Journal of Chinese Medicine, Год журнала: 2025, Номер unknown, С. 1 - 25

Опубликована: Март 18, 2025

Myocardial infarction (MI) is a significant threat to human health worldwide. Following MI, cardiomyocytes (CMs) undergo pyroptosis, exacerbating the damage caused by infarction. Ginseng may play role in alleviating CM pyroptosis. However, further exploration needed regarding its main active ingredients and effects. By employing network pharmacology on of ginseng, MI molecular docking between such pyroptosis-related proteins, we screened for ingredient ginseng. Through docking, identified ginsenoside Rh2, which acts cell as most likely that stably binds proteins. We subsequently constructed neonatal rat oxygen–glucose deprivation (OGD) model vitro an mouse vivo. Ginsenoside Rh2 was administered, with losartan used positive control. In OGD model, increased viability primary CMs mitigated OGD-induced vivo reduced decreased infarct size, improved cardiac function. Our study provides novel therapeutic strategy attenuating

Язык: Английский

Процитировано

0

Ginsenoside Rh2 Alleviates Inflammatory Response and Enhances Motor Function Recovery in Spinal Cord Injury Mice via the ROS/MAPK14 Signaling Pathway DOI Creative Commons

Yanlan Wu,

Fangming Song,

Xiuwei Tan

и другие.

Journal of Ginseng Research, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Ginsenoside Rh2 regulates cardiomyocyte autophagy-dependent apoptosis through the PI3K-Akt-mTOR signaling pathway to attenuate doxorubicin-induced cardiotoxicity DOI Creative Commons
Youping Wu, Sheng Zhang, Liqiang Gu

и другие.

Applied Biological Chemistry, Год журнала: 2025, Номер 68(1)

Опубликована: Апрель 7, 2025

Язык: Английский

Процитировано

0

Research Progress of Genomics Applications in Secondary Metabolites of Medicinal Plants: A Case Study in Safflower DOI Open Access
Zhihua Wu,

Yan Na Hu,

Rui Hao

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(8), С. 3867 - 3867

Опубликована: Апрель 19, 2025

Medicinal plants, recognized as significant natural resources, have gained prominence in response to the increasing global demand for herbal medicines, necessitating large-scale production of these plants and their derivatives. are exposed a variety internal external factors that interact influence biosynthesis accumulation secondary metabolites. With rapid development omics technologies such genomics, transcriptomics, proteomics, metabolomics, multi-omics become important tools revealing complexity functionality organisms. They conducive further uncovering biological activities metabolites medicinal clarifying molecular mechanisms underlying Also, artificial intelligence (AI) technology accelerates comprehensive utilization high-dimensional datasets offers transformative potential analysis. However, there is currently no systematic review summarizing genomic metabolite plants. Safflower (Carthamus tinctorius L.) has rich diverse bioactive flavonoids, among which Hydroxysafflor yellow A (HSYA) specific safflower emerging medication treating wide range diseases. Hence, progress been made study an excellent example regulation recent years. Here, we on understanding main at level, summarize various types contents, with particular focus flavonoids. This aims provide insight into regulatory from perspective genomics.

Язык: Английский

Процитировано

0